Life Sciences Archivi - Pagina 4 di 7

4 settembre 2023

Endoscope Reprocessing Industry Will Witness the Fastest Growth in Hospitals

The endoscope reprocessing market size will touch USD 4,277.6 million by 2030, proceeding at a rate of 9.6% by the end of this decade. This is mostly due to the supportive controlling guidelines promoting endoscope reprocessing, growing disease cases requiring endoscopy procedures, and tech progression in reprocessing approaches.

High-level disinfectants and test strips category had about 34% share in 2022, because of the increasing prevalence of numerous endogenous contaminations, for example bacteremia and pneumonia, after endoscopy procedures. Likewise, the acceptance of test strips is growing for the effective measurement of the MEC needed for high-level disinfection, thus delivering faster disinfection reactions.

Furthermore, they support in the discovery of carbohydrates, residual proteins, and hemoglobin on both flexible and rigid endoscopes, via the chart of color comparison.

Reprocessing is mainly done for flexible endoscopes, therefore bringing about their larger share of revenue, of over 65%, in 2022. This is due to the fact that the protuberant players are actively launching AERs that are extremely compatible with flexible endoscopes.

Actually, about 90% of the companies are working on the development of AERs for flexible endoscopes because of their flexibility for controlling and lower weight.

Alterations in the operating environment, for example the increasing stringency of the regulatory necessities associated with reprocessing, are progressing faster than expected. Controlling authorities are taking initiatives for decreasing the chances of HAI’s throughout analysis and treatment.

Hospitals will grow the fastest with around 10% in the years to come in the endoscope reprocessing market. This is because of the increasing count of endoscopy procedures, in addition to the growing count of hospitals at a global level and the declaration of funds and investments delivered by government institutions.

North America led the industry with a share of about 48%, in 2022. This dominance is because of the increasing frequency of tech advancements, increasing elderly populace, snowballing incidence of chronic diseases, particularly gastric ailments; existence of the big names of the industry, improving healthcare services, and snowballing hospital count.

Moreover, the requirement for endoscopies is growing amongst the elderly populace as it is more susceptible to chronic ailments, for example cardiac ailments, blocked arteries, cancer, and GERD. These need GI endoscopies and colonoscopies for their discovery, therefore leading to a surge in the use of endoscopes.

The U.S. is undergoing a demographic shift with the surge in the count of citizens of 65 years or more. According to the U.S. Census Bureau, the age group of people 65 years and older will increase to approximately 24% by 2060.

There is an increase in the number of cases of diseases which require endoscopy procedures, this has a positive impact on the demand for endoscope reprocessing, all over the globe.

1 settembre 2023

European Biomaterials Market is Led by Germany

The biomaterials market will touch USD 349.1 billion by 2030, powering at a rate of 13.4% in the years to come.

The growth of the industry is encouraged by tech progressions, the increasing prevalence of musculoskeletal and skeletal conditions, and increasing support of the governments, such as funds and grants for increasing the production of advanced biomaterials.

The elderly people require extensive care as they are prone to illnesses, as a result of low immunity and high recovery time. As a result of the changes in tendons and ligaments with age, the flexibility of joints decreases, and their motion turn out to be more restricted.

North America biomaterials market had the largest revenue, about USD 50 billion in the past. This is because of the increasing healthcare spending, increasing support of the government, and growing consciousness regarding implantable medical devices.

Germany has a considerable share in Europe, because of the growing requirement for minimally invasive surgeries, high level of patient consciousness, and the existence of cutting-edge healthcare infra for joint replacement surgery.

It is because of the increasing tech-advancements in the field of medical science, the need for biomaterials is on the rise all over the world.

21 agosto 2023

Nerve Repair and Regeneration Industry Development and Demand Forecast to 2030

The nerve repair and regeneration market will reach over USD 17.47 billion, growing at a 12.2% CAGR, by 2030.

The growth of the industry is mainly credited to the increasing incidence of traumatic brain injuries, along with numerous neurological illnesses, for instance, ataxia, Alzheimer’s disease, and acute spinal cord injury. Additionally, the rising government organization’s support for research on nervous system disorders will further boost the growth of the industry in the years to come.

Furthermore, developing nations, such as Brazil, China, and India are providing profitable growth opportunities for the expansion of the domain. This is attributed to the mounting incidence of neurological disorders, increasing healthcare expenses, and the large population in these nations.

In 2021, the neurostimulation/neuromodulation devices category, based on product, accounted for the largest industry share, of over 64%. This is mainly because of the growing commercialized spinal cord stimulation product numbers, itself because of the increasing number of individuals with spinal cord injuries. Additionally, the technological progressions, the biocompatibility of these devices, and the increasing number of applications are boosting the category growth.

The APAC industry will observe the fastest growth rate, of over 13%, in the years to come. This is because of the mounting elderly population, increasing healthcare expenses, and the rising incidence of neurological illnesses, for instance, Parkinson’s, epilepsy, Alzheimer’s, and essential tremors. Additionally, the implementation of advanced technologies for the treatment of these illnesses is boosting the growth in this region.

In APAC, the nerve regeneration and repair therapies adoption in China, Japan, and India is advancing rapidly because of the growing healthcare infrastructure rate and new technology penetrations.

Hence, with the increasing incidence of traumatic brain injuries and rising research on nervous system disorders, the nerve repair and regeneration industry will advance significantly in the coming years.

11 agosto 2023

Asia-Pacific Grew the Fastest in Sleep Apnea Devices Industry

As per a report published by a market research institution, P&S Intelligence, the sleep apnea devices industry will grow at a compound annual growth rate of 7.2%, to touch USD 13,386.5 million by 2030.

This growth of the industry is because of the increasing incidence of OSA, unhealthy routines of individuals, changes in diet and sleep patterns, and enormous work pressure.

With the development of cutting-edge products, there is an increase in the acceptance of portable devices. For example, products equipped with additional features, for example the usage of an algorithm and pressure sensor for determination of the best pressure, are there in the market.

Therapeutic devices had the larger share. The industry has availability of numerous therapeutic devices for treating sleep apnea in which sleeping aids support the treatment. It will also be faster growing category, advancing at a rate of about 9% by the end of this decade. This growth will mainly be led by the growing OSA cases globally.

North America led the sleep apnea devices market, with about 45% share in 2022. This is because of the increasing incidence of sleeping ailments. Also, the rise in the incidence of a number of health conditions, for example obesity and heart diseases, which are risky factors for sleep apnea will also play a part in the growth of the industry in the region.

The growing elderly population also plays a key role in powering the market growth. With elderly, people suffer from health issues, as a result of psychological features and changes in cardiac rhythm, therefore making them more vulnerable to sleep ailments.

Furthermore, OSA and insomnia are the most common sleeping conditions in aged people. For improving the quality of life and ensuring a healthy lifestyle amongst the elderly population, the requirement for such devices is rapidly on the rise.

The increasing incidence of OSA, and the changing lifestyle of the people has a lot to do with the increasing demand for sleep apnea devices all over the world.

10 agosto 2023

United States Medical Equipment Maintenance Industry was Dominated by Texas

U.S. Medical Equipment Maintenance Industry

The United States medical equipment maintenance market will power at a rate of 9.2% in the years to come, to reach USD 21,358.3 million by 2030, as stated by a market research institution, P&S Intelligence.

This growth will be driven by the progressions in the medical device industry, increasing consciousness on preventive medical equipment upkeep, and a strict regulatory environment.

Preventive maintenance dominated the industry. This will also have the highest growth rate in the years to come. This can be credited to the growing acceptance of AMC policies by hospitals and other users in the nation, because of the numerous reimbursements related to them.

Private-sector organizations will have the larger share in 2030. This has a lot to do with the budding private-sector healthcare sector and increasing healthcare spending.

Among all the states, Texas dominated the industry in the past, and it is expected to grow the fastest in the years to come.

This is mainly due to the presence of a high number of hospitals in the state, coupled with the growing healthcare expenditure. State agencies, such as the HHSC, DADS, and Texas DSHS, had ~83% of all healthcare expenditure in the state on an annual basis.

The users in the medical equipment maintenance market of the nation are becoming more persuaded toward entering into multi-vendor contracts, for reducing the intricacies and further expenses related to separate services delivered under agreements with the builders of medical equipment.

In the country, numerous tech advanced medical devices and associated products are put to use by healthcare specialists and governments to offer best in-class amenities to patients.

As these high-tech medical devices necessitate steady maintenance, software updates, and other kinds of services, their snowballing acceptance will drive the market in the years to come.

The U.S. has a strict regulatory framework, which makes the maintenance of medical equipment a compulsory requirement for users.

According to the regulations, hospitals must follow OEMs suggest preventive maintenance procedures and programs, unless a waiver was executed and accepted by the health department.

With these kinds of regulations in place, the acceptance of medical equipment upkeep services by hospitals and other healthcare facilities will increase, powering the market in the near future.

This market is highly diversified, because of the occurrence of more than a few key players. Recently, major players have taken a number of strategic measures, for example partnerships, mergers and accusations , and facility developments, to gain a competitive edge in the market.

It is because of the growing consciousness on preventive medical equipment upkeep, the demand for medical equipment maintenance, will increase in the years to come in the U.S.

2 agosto 2023

Medical Gloves Industry To Observe Fastest Growth In Asia-Pacific

As per a statement by P&S Intelligence, the medical gloves industry will reach USD 20,435.6 million, propelling at a rate of 10.8%, by 2030.

The growth in the industry is credited to the increasing elderly population, the growing risk of contagious diseases, mounting healthcare expenses, the growing volume of surgeries, and the increasing incidence of chronic diseases.

The medical gloves industry had been positively affected by the COVID-19 pandemic, due to the sudden surge in medical supplies demand.

Based on raw materials, the nitrile category held the largest share of the medical gloves industry in recent years. This is mainly due to its non-allergic properties.

North America is expected to dominate the industry in the years to come, owing to the widespread necessity for medical gloves in healthcare units, and the existence of strong key players.

Moreover, APAC is expected to witness the fastest growth in the coming years, owing to the increasing elderly populace and rising number of surgical procedures and diagnostic examinations.

A key trend observe in the industry is the fondness for non-powdered medical gloves over powdered medical gloves by the customers, due to the non-allergic properties of the non-powdered medical gloves.

In the past few years, players in the industry have been involved in product launches and mergers & acquisitions to maintain a competitive edge.

Hence, due to the increasing elderly pullulation, increasing incidence of chronic diseases, and growing risk of contagious diseases, the medical gloves industry will continue to grow significantly in the years to come.

1 agosto 2023

Global Facial Skin Ablative Treatment Industry Analysis and Future Scope

The global facial skin ablative treatment market is projected to be worth USD 8,394.3 million by 2030, growing at a CAGR of 7.8%, according to P&S Intelligence. This growth can be ascribed to the growing count of aesthetic measures being conducted throughout the globe, the thriving populace of aging individuals, improvements in technology, growing per-capita income, and rising awareness regarding progressive aesthetic treatments, through meetings and conferences.

On the basis of application, the acne and other scars category had the highest revenue share in the facial skin ablative treatment market in the past few years, and it is projected to remain in the leading position in the future as well. This would mainly be because of the high occurrence of acne in both men and women throughout the world.

The Generation Y category led the industry in recent years, on the basis of demography. This is mainly because of the vast populace of the individuals in this age group, joined by the high occurrence of skin illnesses and rising realization regarding looks among them.

In the past few years, North America held the largest share in the facial skin ablative treatment market, and also the region is projected to be dominant in the future as well.

The Asia-Pacific region is projected to grow at the highest development rate in the facial skin ablative treatment market in the coming few years.

This would mainly be because of the rising healthcare investments and personal per-capita income, growing expenditure by manufacturers, growing aesthetic medicinal tourism industry, and rising populace in the region.

As per the United Nations Department of Economic and Social Affairs (UNDESA), the populace of people aged 65 years and more will touch 225.4 million in India, 356.6 million in China, 52.0 million in Brazil, and 84.8 million in the U.S. by 2050.

Hence, the growing count of aesthetic measures being conducted throughout the globe, the thriving populace of aging individuals, improvements in technology, and growing per-capita income, are the major factors contributing to the growth of the facial skin ablative treatment market.

28 luglio 2023

Benign Prostatic Hyperplasia Treatment Industry Growth and Forecast Report 2023-2030

The benign prostatic hyperplasia treatment market will reach USD 18,837.7 million in 2030, with a CAGR of 5.2% in the years to come. The increasing occurrence of BPH, surging preference for minimally invasive surgeries, and growing investments, funds, and grants for conducting research on novel treatments are the protruding contributors to the development.

The larger share, around 85%, was held by drugs. This is because of the growing requirement for alpha-blockers as these medicines relax the muscle of the prostate and bladder neck, enabling urine flowing more easily.

Amongst the diverse types of drugs, alpha-blockers have been extensively used for treating the disease recently. Their increasing usage and the abundance of medicines under expansion present potential prospects for the industry.

Home healthcare settings had the larger share, and they will record the higher rate, over 5%, in the years to come, as a result of the growing patient count prescribed drugs over surgical treatment.

North America dominated the BPH treatment market with 41% share, as stated by a market research firm, P&S Intelligence. The increasing occurrence of the problem is powering the acceptance of cutting-edge treatments, for example, prostatic stenting, laser therapy, and UroLift therapy, thereby powering the development of the industry in the region.

APAC will grow the fastest in the years to come, at a rate of 6.4%. The improving standards of living, increasing per capita income and spending ability, snowballing burden of urological disease, and increasing investment in the healthcare for boosting the progress.

Furthermore, the increasing aging male population, together with a boom in the occurrence of obesity and diabetes, will power the prevalence of BPH and other lower urinary tract conditions.

China, India and Japan together have a large aging male population, requiring regular medical assistance, being extremely susceptible to chronic ailments as a result of its low immunity.

Therefore, patients with an irregular growth of the prostate are needed to be treated, to prevent urethra blockage and decrease the related cancer risk.

The increasing elderly male population is the main reason for the growing demand for BPH treatment all over the world.

27 luglio 2023

North America Is Dominating Professional Acne Treatment Industry

The global professional acne treatment market is experiencing growth and is projected to reach USD 13,124.5 million by 2030. This development can be credited to the increasing occurrence of acne, rising per-capita income in emerging and emerging nations, growing healthcare expenditure, and the rising count of research events.

In recent years, Inflammatory acne had the largest industry share, on the basis of acne type. This is mainly because of the instant need for better-quality treatment as it is normally painful.

Additionally, the generally accessible salicylic acid and benzoyl-peroxide-based over-the-counter items are not completely effective on inflammatory spots. Then, branded and common medications are provided by key medicinal businesses, on prescription, for inflammatory spots.

In the coming few years, the devices category is projected to experience faster development in the professional acne treatment industry, on the basis of treatment type. This can be ascribed to the increasing acceptance of light-based and laser acne treatments, largely in advanced countries, credited to the side effects of medications.

On the basis of professional type, in recent years, the dermatologist’s category is projected to dominate the professional acne treatment industry. This is mainly because of the growing count of expert dermatologists treating skin illnesses, like acne. Moreover, patients choose dermatologists due to their wide expertise and experience in dealing with the issue.

In recent years, North America led the industry, mainly because of the increasing occurrence of acne, growing knowledge of afresh developed medications, the huge pipeline of medications, and high per-capita income in the continent.

Furthermore, the continent is marked by the existence of protuberant dermatology medication producers, including Pfizer Inc., Johnson & Johnson, and Bausch Health Companies Inc., who offer several classes of medications to the North American populace.

Several pharmaceutical businesses are introducing new products, which have become a key trend in the industry for expert acne treatment items. For example, in 2020, Cassiopea SpA got the U.S. Food and Drug Administration (FDA) sanction for Winlevi, a clascoterone-founded cream made for the cure of acne in patients 13 years and elder.

Furthermore, AnnJi Pharmaceutical Co. Ltd. is involved in the growth of AJ101, which is an up-to-date cream formulation for the cure of acne vulgaris. The active element in AJ101 is a new androgen receptor degradation enhancer, which efficiently reduces the level of activity.

Individuals are concentrating on improving their looks by actively spending on a wide-ranging skincare regimen for scars, acne, and other skin issues. There are numerous treatment choices obtainable, such as systemic agents, topical therapies, lasers, physical modalities, and photodynamic therapy.

Hence, the increasing occurrence of acne, rising per-capita income in emerged and emerging nations, growing healthcare expenditure, and the rising count of research events are the major factors propelling the professional acne treatment market.

20 luglio 2023

Eye Testing Equipment Industry IS Dominated by North America

According to the report of P&S Intelligence, the size of the eye testing equipment market was USD 2,852.2 million in 2021, and it will increase to USD 5,246.1 million by 2030, powering at a rate of 7% in the years to come.

Glaucoma will have the fastest growth, at a rate of 8%, in the years to come, as this eye disorder is extremely predominant. In 2020, about 78 million people had glaucoma, and this will be approximately 110 million by 2040.

OCT and tonometry support in diagnosing glaucoma, that is the reason why the rising frequency of this illness will power the requirement for OCT devices and tonometers.

North America dominated the industry with around 35%, in the past. This has a lot to do with the widespread use of cutting-edge products in eye care services, along with the high spending on this feature of human health. By the way, the increasing elderly population and growing consciousness about eye care will drive the growth of the industry in the years to come.

APAC followed North America, and its industry will grow at a considerable rate in the years to come. This will be since of the increasing count of people with vision loss, which will pose a challenge to eye care providers, prompting them to obtain advanced equipment for diagnosis.

It is because of the advancement in the technology of ophthalmic diagnostics, the demand for eye testing equipment will be on the rise in the years to come.